Locked
Latest trials show Pfizer Covid-19 vaccine to be 90% effective – With insights from the Wall Street Journal
Pfizer and its partner BioNTech plan to seek FDA authorisation by the end of November to sell the vaccine, pending safety data.
No matter how much critics argue that Covid-19 is not the existential threat first imagined, today's reality is that because of the hype, cautious lawmakers are reluctant to take any chances. As a result, until an effective vaccine is widely available, regulations that hurt economic activity will remain in force. Little wonder last night's breakthrough news from Pfizer and BioNTech was warmly applauded by investors, sending major US stock market indices briefly back into record territory. Here's the full story from our partners at the Wall Street Journal. – Alec Hogg
THE WALL STREET JOURNAL
___STEADY_PAYWALL___